Adial Pharma Touts Positive Preclinical Data From Chronic Pain Candidate
Adial Pharmaceuticals Inc’s (NASDAQ:ADIL) subsidiary, Purnovate Inc, achieved positive in vivo data for PNV-5030 as a potential treatment for chronic pain.…
Lipocine To Focus On Central Nervous System Conditions; Explores Partnerships For Non-Core Assets
Lipocine Inc (NASDAQ:LPCN) announced its plans to focus on treating Central Nervous System (CNS) disorders. The company’s priority is to advance…
Arcutis Shares Gain On Positive Phase 3 Data On Roflumilast Foam In Scalp, Body Psoriasis
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) announced topline results from the ARRECTOR Pivotal Phase 3 trial of roflumilast foam 0.3% for treating adults…
Atea Pharma’s Investigational Dengue Treatment Fast Tracked In US
The FDA has granted Fast Track Designation for Atea Pharmaceuticals Inc’s (NASDAQ:AVIR) AT-752 for treating dengue virus infection. AT-752, a novel, orally…
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the booster in children six months through 5 years later this year.
Cathie Wood Loads Up $23M In Gene-Editing Company’s Shares As They Slump 10% In A Month
Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.
Needham Downgrades This Medical Equipment Stock Due To Lawsuit Risk
A Cook County jury awarded $363 million to a woman who developed breast cancer after living close to a medical…
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
The White House announced $1.5 billion in funding to tackle opioid overdoses, sanctions against traffickers, and increased funding for law…
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
Pfizer Inc (NASDAQ:PFE) and its partner Sangamo Therapeutics Inc (NASDAQ:SGMO) have reopened enrollment in phase 3 AFFINE study hemophilia A gene therapy trial. …
After Regulatory Setback, Spectrum Pharma Secures Up To $65M In Debt Funding
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) entered into a five-year debt financing agreement with SLR Capital Partners for a term loan…